|
|
||||||||||
|
J Am Coll Cardiol, 2006; 48:1355-1360, doi:10.1016/j.jacc.2006.05.059
(Published online 12 September 2006). © 2006 by the American College of Cardiology Foundation |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy.
Manuscript received March 24, 2006; revised manuscript received May 8, 2006, accepted May 8, 2006.
* Reprint requests and correspondence: Dr. Leonarda Galiuto, Institute of Cardiology, Catholic University of the Sacred Heart, Policlinico A. Gemelli, Largo A. Gemelli 8, 00168 Rome, Italy. (Email: lgaliuto{at}rm.unicatt.it).
| Abstract |
|---|
|
|
|---|
BACKGROUND: Fifty consecutive patients entered the myocardial contrast echocardiography (MCE) substudy of the REMEDIA (Randomized Evaluation of the Effect of Mechanical Reduction of Distal Embolization by Thrombus Aspiration in Primary and Rescue Angioplasty) trial, which defined the role of a new thrombus-aspirating device in preventing distal microembolization after PCI.
METHODS: A total of 25 patients were randomized to be pretreated with thrombus aspiration before PCI of the culprit lesion and 25 received standard PCI. At 24 h, 1 week, and 6 months after PCI, MCE was performed by Sonovue, and real-time imaging was performed by contrast pulse sequencing technology. Regional wall motion score index (WMSI), contrast score index (CSI), endocardial length of wall motion abnormality (WML) and contrast defect (CDL), end-diastolic and end-systolic left ventricular (LV) volumes, and ejection fraction were calculated.
RESULTS: At each time point, in patients treated with a thrombus-aspiration filter device, WMSI, CSI, WML, and CDL were significantly lower and ejection fraction higher (p < 0.05 vs. control patients), whereas LV volumes were slightly but not significantly smaller compared with control patients. In the overall study population, the extent of MO significantly correlated with temporal changes in LV volumes.
CONCLUSIONS: Thrombus aspiration used at the time of PCI significantly reduces the extent of MO and myocardial dysfunction, although it does not have a significant favorable effect in preventing LV remodeling. Thus, the beneficial effect of thrombus aspiration occurs at the microvascular level, but additional mechanisms may play a role in influencing the final extent of MO, which strictly correlates with post-infarct LV remodeling.
| |||||||||||||
We and others have recently shown (2,3) that use of a thrombus-aspirating device during PCI significantly improves the angiographic and electrocardiographic evidence of myocardial reperfusion. To demonstrate the potential benefit of thrombus aspiration at the microvascular level, a subgroup of patients enrolled in the REMEDIA (Randomized Evaluation of the Effect of Mechanical Reduction of Distal Embolization by Thrombus Aspiration in Primary and Rescue Angioplasty) trial underwent myocardial contrast echocardiography (MCE) evaluation.
| Materials and methods |
|---|
|
|
|---|
Angiographic methods have been previously described (2). Briefly, in patients randomized to standard PCI, after crossing the target lesion with the guidewire, direct stent implantation was attempted if judged possible by the operator, whereas in the remaining cases, predilation with an undersized balloon was used before stent implantation. In patients randomized to manual thrombus aspiration, after placement of the guidewire, stenting was preceded by thrombus aspiration by Diver CE (Invatec, Brescia, Italy). All patients were treated with heparin, aspirin, clopidogrel, or abciximab according to conventional protocols (2).
MCE. Conventional echocardiogram and MCE were performed in all patients within 24 h (19.9 ± 12.3 h) of coronary recanalization, at 1 week, and at 6 months.
Myocardial contrast echocardiography studies were performed using real-time contrast pulse sequencing operating on a Sequoia ultrasound system (Siemens, Malvern, Pennsylvania). Contrast pulse sequencing is a novel real-time MCE method that, thanks to the analysis of non-linear response of contrast bubbles in fundamental and higher harmonics, is able to provide an image with excellent signal-to-noise ratio and with particularly high sensitivity and penetration using a very low mechanical index (Fig. 1). A second-generation ultrasound contrast agent Sonovue (Bracco, Milan, Italy) was administered intravenously (5 ml at 1 ml/min).
|
Myocardial opacification at MCE was visually assessed in each of the 16 myocardial segments and semiquantitatively scored. Single perfusion score was assigned on the basis of both the change in myocardial signal intensity throughout the replenishment curve and the degree of opacification at the peak contrast effect (4). Scores were graded as 1 = normal, 2 = reduced, or 3 = absent opacification. A contrast score index (CSI) was calculated by the sum of MCE score in each segment divided by the total number of segments. Endocardial length of severe WM abnormality (WM score = 3) (WML) and of transmural contrast defect (CD score = 3) (CDL) were calculated in each apical view, averaged, and expressed as a percentage of LV length.
Statistical analysis. Continuous variables (presented as mean ± SD) were compared by Student t test for normally distributed variables and by Wilcoxon test for non-normally distributed variables. Categorical variables were expressed as number of subjects and percentages and were analyzed by the chi-square or Fisher exact test, as appropriate. Changes over time of continuous variables and comparison among groups were carried out using 2-way analysis of variance for repeated measures and Scheffes F test. A linear regression analysis was carried out to correlate continuous variables with the percentage change of LV volumes at follow-up. Cohens kappa statistical analysis was performed to measure intra- and interobserver agreement of MCE score and LV volume analysis. Statistical analysis was performed with the use of the SPSS software package for Windows 11.0 (SPSS Inc., Chicago, Illinois). Differences were considered significant at p < 0.05.
Reproducibility. To assess intraobserver variability of MCE analysis, 16 MCE studies obtained in the first 8 patients were independently reviewed by the same observer (L.G.), 40 ± 10 days after initial scoring. Segments with signal attenuation and artifacts were excluded from analysis. Interobserver variability was assessed by comparing the reading of 2 observers (L.G., A.L.). Intraobserver and interobserver variability of CSI analysis was 3.2 ± 2% and 4.2 ± 2% (absolute difference), with a K value for agreement of 0.91 and 0.95, respectively. For LV volume analysis, intra- and interobserver variability was 3.4 ± 1% and 5.1 ± 2%, with a K value for agreement of 0.89 and 0.93, respectively.
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Assessment of post-PCI perfusion at microvascular level. Mechanical reopening of thrombotic coronary occlusion by balloon angioplasty and stent placement is the most effective way to re-establish flow within the infarct area, thus limiting necrosis extent. However, this invasive maneuver is responsible for displacement of plaque and thrombus fragments that embolize distally. When the amount of displaced material is consistent, an abrupt obliteration of coronary branches may be recognized at coronary angiogram performed soon after successful PCI (1). However, coronary angiography is able to detect only microembolization responsible for the plugging of vessels with a diameter >100 microns, thus underestimating the phenomenon. Surrogate markers of microvascular perfusion, such as resolution of electrocardiographic elevation and myocardial blush grade, have been used to assess the efficacy of PCI at tissue level. In this study, we elected to assess post-PCI MO by MCE because this technique is readily available in our institution at patients bedside in the coronary care unit, effective in the evaluation of MO, well tolerated by the patients, and easily repeatable to perform serial assessment (5).
The results of this study demonstrate that post-PCI microembolization plays a significant role in the pathogenesis of MO, because aspiration of thrombotic material significantly reduces the severity and extent of MO.
Temporal changes of microvascular obstruction and myocardial dysfunction. A collateral finding of this study is that, in both treated and control patients, MO progressively improves over time at 1 week and 6 months follow-up. This temporal change in MO extent is paralleled by similar temporal improvement of regional WM. These findings are in close agreement with the demonstration of dynamic changes of post-infarct microvascular damage characterized by a progressive reduction of MO at serial MCE evaluation (5,6). It is conceivable that temporal changes of MO are the result of progressive resolution of mechanisms that concur in the pathogenesis of post-PCI MO, such as microvascular spasm or reduction of tissue edema and microvessel compression or resolution of leukocyte plugging. Temporal reduction of myocardial dysfunction may be interpreted as the resolution of myocardial stunning, and such temporal resolution may be enhanced by the parallel reduction of MO extent.
Prevention of distal embolization and LV remodeling. End-diastolic and -systolic LV volumes are the best predictors of patient survival after acute myocardial infarction, and the extent of MO has already been demonstrated to be closely linked to post-infarct LV dilation and remodeling (7). So it is reasonable to expect that a thrombus-aspiration-related reduction in MO is associated with limited LV remodeling. Yet, in this study, end-diastolic and end-systolic LV volumes were slightly but not significantly smaller in treated patients compared with control patients. Because the study sample was powered to demonstrate a possible effect of thrombus aspiration on MO, a larger study population probably is needed to demonstrate prevention of LV remodeling. Regardless, a possible reason for the limited effect of thrombus aspiration on LV volumes may be the multiple pathogenic causes of MO, so that the reduction of only 1 factor, such as microembolization, is sufficient to reduce MO, but to an extent insufficient to prevent LV remodeling. In a randomized trial with a design similar to our REMEDIA study, de Luca et al. (3) were able to demonstrate a significant reduction in both end-diastolic and end-systolic LV volumes by the same thrombus-aspiration device. However, all 75 patients included in their study exhibited anterior wall acute myocardial infarction, which might have highlighted potential beneficial effects of thrombus aspiration, although information on the extent of MO was not provided.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Di Mario and G. Ferrante Embolization: The "Dark Side" of Percutaneous Coronary Interventions J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 277 - 278. [Full Text] [PDF] |
||||
![]() |
L. Galiuto, B. Garramone, A. Scara, A. G. Rebuzzi, F. Crea, G. La Torre, S. Funaro, M. Madonna, F. Fedele, L. Agati, et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. J. Am. Coll. Cardiol., February 5, 2008; 51(5): 552 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Worthley and S. G. Worthley Is thrombus aspiration the appropriate "remedy"? J. Am. Coll. Cardiol., April 17, 2007; 49(15): 1670 - 1670. [Full Text] [PDF] |
||||
![]() |
F. Burzotta, F. Crea, and L. Galiuto Reply. J. Am. Coll. Cardiol., April 17, 2007; 49(15): 1671 - 1671. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |